Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Published:2015-12-03 Issue:23 Volume:373 Page:2247-2257
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Pfeffer Marc A.,Claggett Brian,Diaz Rafael,Dickstein Kenneth,Gerstein Hertzel C.,Køber Lars V.,Lawson Francesca C.,Ping Lin,Wei Xiaodan,Lewis Eldrin F.,Maggioni Aldo P.,McMurray John J.V.,Probstfield Jeffrey L.,Riddle Matthew C.,Solomon Scott D.,Tardif Jean-Claude

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1509225

Cited by 1903 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucose lowering drug or strategy dependent impact of weight reduction on the prevention of CVD outcomes in Type 2 diabetes: a systematic review of CVOTs;Diabetes Research and Clinical Practice;2024-10

2. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases;Metabolism;2024-10

3. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction;Heart Failure Reviews;2024-09-13

4. Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes;Expert Opinion on Drug Metabolism & Toxicology;2024-09-13

5. The use of composite endpoints in cardiovascular outcome trials for diabetes: A review of 22 randomized clinical trials published since 2008;Diabetes, Obesity and Metabolism;2024-09-02